Pharmaceutical companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under 2 spellings of its name, each linked to the record.
As of Nov 14, 2026, FDA's public records list Sprout Pharmaceuticals with 2 OPDP letters and 1 drug application. The most recent is an OPDP letter dated May 29, 2025: Warning letter: Addyi.
| May 29, 2025 | Warning letter: AddyiOffice of Prescription Drug Promotion | OPDP letters |
| Aug 31, 2020 | Warning letter: AddyiOffice of Prescription Drug Promotion | OPDP letters |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built
